Skip to content

The effect of magnesium in idiopathic tinnitus

Clinical trial of the effect of magnesium compared to placebo in idiopathic tinnitus

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160813029327N26
Enrollment
60
Registered
2024-10-04
Start date
2024-11-05
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tinnitus. Tinnitus

Interventions

Intervention 1: Intervention group:For people who met the criteria for entering the research, they will receive a magnesium tablet in the form of 250 mg tablet - jalinous every day for two months. Int

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Idiopathic tinnitus Patients over 18 years old and under 65 years old Informed consent

Exclusion criteria

Exclusion criteria: Taking anticoagulant drugs Pregnancy or intention to become pregnant Not feeling well Observation of any unpredictable complications Non-cooperation in psychoacoustic assessments The presence of pulsating tinnitus History of otological and neurological disease Breastfeeding Vitamin D deficiency

Design outcomes

Primary

MeasureTime frame
Tinnitus annoyance index and psychoacoustic assessments of tinnitus. Timepoint: At the beginning of the study (before the intervention) and 60 days after starting the treatment. Method of measurement: Tinnitus Handicap Inventory (THI) questionnaire and determination of perceived loudness of tinnitus by the patient through LMT, PMT, MML.

Secondary

MeasureTime frame
Hearing threshold. Timepoint: At the beginning of the study (before the intervention) and 60 days after starting the treatment. Method of measurement: Audiogram chart or ear tape.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactYounes Lotfi

Shahid Beheshti University of Medical Sciences

yones1333@gmail.com+98 21 2220 5326

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026